NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Joe Biden
    United States of America
    COVID-19
    Russia-Ukraine crisis
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / World News / After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
    World

    After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK

    After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK
    Written by Siddhant Pandey
    Dec 30, 2020, 01:37 pm 2 min read
    After Pfizer, Oxford-AstraZeneca's COVID-19 vaccine approved in UK

    The COVID-19 vaccine developed by Oxford University and AstraZeneca has been approved for use in the United Kingdom. This would help boost the immunization program in the UK, which has already approved and rolled out the vaccine developed by Pfizer and BioNTech. The vaccine is also under consideration for roll out in India as 'Covishield' under a partnership with the Serum Institute of India.

    Vaccinations expected to start next week

    The UK's Medicines and Healthcare products Regulatory Agency (MHRA) on Wednesday approved the Oxford University-AstraZeneca's vaccine, declaring the vaccine safe and effective. The vaccine is reportedly expected to be rolled out next week. The UK has ordered 100 million doses of the vaccine, which would be enough to vaccinate 50 million people as it is a two-dose vaccine.

    Over 6 lakh vaccinated by Pfizer's shot in UK

    Earlier in December, the UK had approved Pfizer-BioNTech's vaccine for use in the country. Since 90-year-old Margaret Keenan became the first in the world to get that vaccine outside of a clinical trial on December 8, over six lakh people in the UK have received the vaccine. However, AstraZeneca's vaccine is cheaper and easier to mass-produce compared to Pfizer's shot.

    Oxford-AstraZeneca's vaccine can be stored in standard fridge

    Notably, the Pfizer-BioNTech vaccine doses need to be stored at temperatures as low as -70°C, which requires expensive ultra-cold storage. However, the AstraZeneca vaccine can be stored in a standard fridge, making vaccine delivery more feasible.

    How was the vaccine made?

    The potential vaccine consists of the replication-deficient chimpanzee viral vector (ChAdOx1) based on a weakened version of a common cold virus (adenovirus) containing the genetic material of the SARS-CoV-2 virus spike protein. After vaccination, the spike protein produced triggers an immune response that offers protection against future SARS-CoV-2 infections. The vaccine has been found to have an average efficacy of 70%.

    When will the vaccine be approved in India?

    Covishield is among the potential vaccines awaiting emergency approval in India. Reportedly, it is expected to be approved in the coming days. SII CEO Adar Poonawalla has said that the vaccine will be rolled out in India by January. The institute is aiming to make 300 million doses by July 2021 and 40-50 million doses have already been prepared, Poonawalla has said.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    Oxford University
    Coronavirus
    AstraZeneca
    Covishield

    Oxford University

    Oxford/AstraZeneca vaccine should be effective against new variant: Report Coronavirus
    Dharavi logs zero coronavirus cases for first time since April World Health Organization
    Russia, AstraZeneca to test combination of COVID-19 shots Vladimir Putin
    Oxford-AstraZeneca release final-stage trial results, coronavirus vaccine labeled safe Oxford

    Coronavirus

    New coronavirus strain scare: India-UK flights suspended till January 7 India
    Singapore starts COVID -19 vaccination for healthcare workers Singapore
    India reports 14 new cases of mutant coronavirus strain India
    Coronavirus: India's tally reaches 10.24 million with 20K+ new cases India

    AstraZeneca

    Indian government could approve Oxford-AstraZeneca's coronavirus vaccine by next week India
    Here's how the government is planning to conduct COVID-19 vaccinations Times of India
    Trial will continue: Centre on SII vaccine's "adverse reaction" claims Central Drugs Standard Control Organization (CDSCO)
    SII to sue vaccine trial participant for Rs. 100 crore Oxford

    Covishield

    Centre extends COVID-19 surveillance guidelines till January 31 India
    COVID-19 vaccine: Centre to start dry run in four states India
    No emergency approval for SII, Bharat Biotech's vaccine candidates yet Serum Institute of India
    SII says Covishield 'safe' after trial participant sends legal notice Oxford University

    Love World News?

    Subscribe to stay updated.

    World Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023